跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确围绕死亡截断结局、主层化及因果参数的识别与估计展开。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Peng Ding
Zhi Geng
Wei Yan
Xiao-Hua Zhou

死亡截断结局下主层化因果效应的可识别性与估计

研究问题
当研究对象在结局测量前死亡时,如何通过主层化识别和估计因果参数,并避免依赖结局服从正态混合分布的假设?
方法与思路
作者提出非参数与半参数识别方法,利用处理前协变量在两个主层中条件分布不同的假设,并研究假设违反时的偏差和减偏方法。
材料陈述的贡献
摘要称,在协变量差异及一些正则假设下因果参数可识别,方法适用于连续和二元结局,并以模拟及肿瘤临床试验数据评估。
阅读关注点
应核对目标因果参数、两个主层的定义、协变量条件分布差异和其他识别假设,检查这些条件的可检验性及减偏方法的范围。
阅读边界
仅据版本未注明的 OpenAlex 索引摘要;完整识别条件、偏差表达式和数值结果未说明,不能仅凭协变量差异确认识别或推断刊本变化。

原文摘要

In medical studies, there are many situations where the final outcomes are truncated by death, in which patients die before outcomes of interest are measured. In this article we consider identifiability and estimation of causal effects by principal stratification when some outcomes are truncated by death. Previous studies mostly focused on large sample bounds, Bayesian analysis, sensitivity analysis. In this article, we propose a new method for identifying the causal parameter of interest under a nonparametric and semiparametric model. We show that the causal parameter of interest is identifiable under some regularity assumptions and the assumption that there exists a pretreatment covariate whose conditional distributions among two principal strata are not the same, but our approach does not need the assumption of a mixture normal distribution for outcomes as required by Zhang, Rubin, and Mealli (2009). Hence, the proposed method is applicable not only to a continuous outcome but also to a binary outcome. When some of the assumptions are violated, we discuss biases of estimators and propose methods to reduce these biases. We conduct several simulation studies to evaluate the finite-sample performance of the proposed approach. Finally, we apply the proposed approach to a real dataset from a Southwest Oncology Group (SWOG) clinical trial.

笔记与分组
相关领域论文